Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04993677
Title A Study of SEA-CD40 Given With Other Drugs in Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seagen Inc.

lung non-squamous non-small cell carcinoma

uveal melanoma



Carboplatin + Pembrolizumab + Pemetrexed Disodium + SEA-CD40

Pembrolizumab + SEA-CD40

Age Groups: senior | adult
Covered Countries USA | ESP | CAN

No variant requirements are available.